IONS logo

Ionis Pharmaceuticals, Inc. (IONS) Revenue

Annual revenue:

$705.14M-$82.51M(-10.48%)
December 31, 2024

Summary

  • As of today (August 20, 2025), IONS annual revenue is $705.14 million, with the most recent change of -$82.51 million (-10.48%) on December 31, 2024.
  • During the last 3 years, IONS annual revenue has fallen by -$105.32 million (-12.99%).
  • IONS annual revenue is now -37.19% below its all-time high of $1.12 billion, reached on December 31, 2019.

Performance

IONS Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

Quarterly revenue:

$452.05M+$320.44M(+243.47%)
June 30, 2025

Summary

  • As of today (August 20, 2025), IONS quarterly revenue is $452.05 million, with the most recent change of +$320.44 million (+243.47%) on June 30, 2025.
  • Over the past year, IONS quarterly revenue has increased by +$226.80 million (+100.69%).
  • IONS quarterly revenue is now -8.43% below its all-time high of $493.68 million, reached on December 31, 2019.

Performance

IONS Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

TTM revenue:

$944.48M+$226.80M(+31.60%)
June 30, 2025

Summary

  • As of today (August 20, 2025), IONS TTM revenue is $944.48 million, with the most recent change of +$226.80 million (+31.60%) on June 30, 2025.
  • Over the past year, IONS TTM revenue has increased by +$130.52 million (+16.04%).
  • IONS TTM revenue is now -15.87% below its all-time high of $1.12 billion, reached on December 31, 2019.

Performance

IONS TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

IONS Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.5%+100.7%+16.0%
3 y3 years-13.0%+237.9%+11.3%
5 y5 years-37.2%+210.6%+0.4%

IONS Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-13.0%+20.1%at high+278.3%at high+64.0%
5 y5-year-37.2%+20.1%at high+305.0%at high+64.0%
alltimeall time-37.2%>+9999.0%-8.4%>+9999.0%-15.9%>+9999.0%

IONS Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$452.05M(+243.5%)
$944.48M(+31.6%)
Mar 2025
-
$131.61M(-42.0%)
$717.68M(+1.7%)
Dec 2024
$705.14M(-10.5%)
$227.00M(+69.6%)
$705.56M(-12.2%)
Sep 2024
-
$133.81M(-40.6%)
$803.56M(-1.3%)
Jun 2024
-
$225.25M(+88.5%)
$813.95M(+4.7%)
Mar 2024
-
$119.50M(-63.2%)
$777.12M(-1.4%)
Dec 2023
$787.65M(+34.1%)
$325.00M(+125.4%)
$788.14M(+28.1%)
Sep 2023
-
$144.21M(-23.5%)
$615.14M(-2.5%)
Jun 2023
-
$188.41M(+44.3%)
$630.70M(+9.5%)
Mar 2023
-
$130.52M(-14.1%)
$576.08M(-1.9%)
Dec 2022
$587.37M(-27.5%)
$152.00M(-4.9%)
$587.48M(-32.9%)
Sep 2022
-
$159.77M(+19.4%)
$875.48M(+3.1%)
Jun 2022
-
$133.79M(-5.7%)
$848.80M(+1.0%)
Mar 2022
-
$141.92M(-67.7%)
$840.76M(+3.7%)
Dec 2021
$810.46M(+11.1%)
$440.00M(+230.6%)
$810.45M(+22.7%)
Sep 2021
-
$133.09M(+5.8%)
$660.45M(-3.9%)
Jun 2021
-
$125.75M(+12.7%)
$687.44M(-2.8%)
Mar 2021
-
$111.61M(-61.5%)
$707.22M(-3.0%)
Dec 2020
$729.26M(-35.0%)
$290.00M(+81.2%)
$728.98M(-21.8%)
Sep 2020
-
$160.08M(+10.0%)
$932.66M(-0.8%)
Jun 2020
-
$145.54M(+9.1%)
$940.48M(-1.9%)
Mar 2020
-
$133.37M(-73.0%)
$958.75M(-14.6%)
Dec 2019
$1.12B(+87.2%)
$493.68M(+194.0%)
$1.12B(+36.7%)
Sep 2019
-
$167.89M(+2.5%)
$821.03M(+2.8%)
Jun 2019
-
$163.81M(-44.9%)
$798.53M(+6.1%)
Mar 2019
-
$297.21M(+54.7%)
$752.47M(+25.5%)
Dec 2018
$599.67M(+16.6%)
$192.11M(+32.1%)
$599.67M(+4.2%)
Sep 2018
-
$145.40M(+23.5%)
$575.35M(+4.9%)
Jun 2018
-
$117.75M(-18.5%)
$548.27M(+1.0%)
Mar 2018
-
$144.42M(-13.9%)
$542.80M(+5.6%)
Dec 2017
$514.18M(+48.3%)
$167.79M(+41.8%)
$514.18M(+1.5%)
Sep 2017
-
$118.31M(+5.4%)
$506.74M(+1.5%)
Jun 2017
-
$112.27M(-3.0%)
$499.35M(+17.3%)
Mar 2017
-
$115.80M(-27.8%)
$425.55M(+22.8%)
Dec 2016
$346.62M(+22.2%)
$160.35M(+44.6%)
$346.62M(+45.7%)
Sep 2016
-
$110.93M(+188.3%)
$237.84M(+35.1%)
Jun 2016
-
$38.47M(+4.3%)
$176.04M(-31.8%)
Mar 2016
-
$36.87M(-28.5%)
$257.99M(-9.1%)
Dec 2015
$283.70M(+32.5%)
$51.57M(+5.0%)
$283.70M(-10.5%)
Sep 2015
-
$49.12M(-59.2%)
$316.99M(+1.6%)
Jun 2015
-
$120.43M(+92.4%)
$311.94M(+25.5%)
Mar 2015
-
$62.58M(-26.3%)
$248.58M(+16.1%)
Dec 2014
$214.16M(+45.4%)
$84.86M(+92.6%)
$214.16M(+24.8%)
Sep 2014
-
$44.06M(-22.8%)
$171.55M(+13.6%)
Jun 2014
-
$57.08M(+102.7%)
$151.07M(+14.4%)
Mar 2014
-
$28.16M(-33.3%)
$132.09M(-10.3%)
Dec 2013
$147.28M(+44.3%)
$42.25M(+79.1%)
$147.29M(+17.9%)
Sep 2013
-
$23.59M(-38.1%)
$124.91M(+10.6%)
Jun 2013
-
$38.09M(-12.1%)
$112.93M(-7.6%)
Mar 2013
-
$43.36M(+118.2%)
$122.17M(+19.7%)
Dec 2012
$102.05M(+3.0%)
$19.87M(+71.3%)
$102.05M(-10.9%)
Sep 2012
-
$11.60M(-75.5%)
$114.58M(-7.4%)
Jun 2012
-
$47.34M(+103.7%)
$123.69M(+22.3%)
Mar 2012
-
$23.23M(-28.3%)
$101.17M(+2.1%)
Dec 2011
$99.09M(-8.7%)
$32.40M(+56.4%)
$99.09M(+6.4%)
Sep 2011
-
$20.71M(-16.6%)
$93.10M(-7.8%)
Jun 2011
-
$24.82M(+17.4%)
$101.01M(+1.3%)
Mar 2011
-
$21.15M(-20.0%)
$99.69M(-8.1%)
Dec 2010
$108.47M(-10.8%)
$26.42M(-7.7%)
$108.47M(-5.1%)
Sep 2010
-
$28.62M(+21.8%)
$114.31M(+1.6%)
Jun 2010
-
$23.50M(-21.5%)
$112.46M(-6.2%)
Mar 2010
-
$29.93M(-7.2%)
$119.95M(-1.4%)
Dec 2009
$121.60M(+13.4%)
$32.26M(+20.5%)
$121.60M(+10.5%)
Sep 2009
-
$26.77M(-13.6%)
$110.00M(-4.7%)
Jun 2009
-
$30.99M(-1.8%)
$115.44M(-1.7%)
Mar 2009
-
$31.58M(+52.8%)
$117.41M(+9.5%)
Dec 2008
$107.19M(+54.0%)
$20.66M(-35.9%)
$107.19M(-3.7%)
Sep 2008
-
$32.22M(-2.3%)
$111.26M(+22.3%)
Jun 2008
-
$32.96M(+54.4%)
$90.96M(+47.2%)
Mar 2008
-
$21.35M(-13.6%)
$61.82M(+44.1%)
Dec 2007
$69.62M
$24.73M(+107.4%)
$42.91M(+42.4%)
DateAnnualQuarterlyTTM
Sep 2007
-
$11.92M(+212.6%)
$30.13M(+40.4%)
Jun 2007
-
$3.81M(+55.6%)
$21.46M(-2.6%)
Mar 2007
-
$2.45M(-79.5%)
$22.02M(-10.2%)
Dec 2006
$24.53M(-38.9%)
$11.95M(+267.2%)
$24.53M(-9.9%)
Sep 2006
-
$3.25M(-25.6%)
$27.23M(-13.4%)
Jun 2006
-
$4.38M(-11.8%)
$31.43M(-16.5%)
Mar 2006
-
$4.96M(-66.1%)
$37.65M(-6.2%)
Dec 2005
$40.13M(-5.8%)
$14.64M(+96.3%)
$40.13M(+8.8%)
Sep 2005
-
$7.46M(-29.6%)
$36.88M(-4.2%)
Jun 2005
-
$10.59M(+42.3%)
$38.51M(+2.0%)
Mar 2005
-
$7.44M(-34.6%)
$37.76M(-11.4%)
Dec 2004
$42.62M(-14.7%)
$11.38M(+25.2%)
$42.62M(+4.1%)
Sep 2004
-
$9.09M(-7.6%)
$40.94M(-5.1%)
Jun 2004
-
$9.84M(-20.0%)
$43.14M(-10.7%)
Mar 2004
-
$12.30M(+26.8%)
$48.31M(-3.4%)
Dec 2003
$49.99M(-37.7%)
$9.70M(-14.1%)
$49.99M(-19.6%)
Sep 2003
-
$11.29M(-24.8%)
$62.15M(-12.7%)
Jun 2003
-
$15.02M(+7.4%)
$71.16M(-6.6%)
Mar 2003
-
$13.98M(-36.0%)
$76.20M(-5.0%)
Dec 2002
$80.18M(+50.5%)
$21.86M(+7.7%)
$80.18M(+0.1%)
Sep 2002
-
$20.30M(+1.2%)
$80.06M(+1.3%)
Jun 2002
-
$20.06M(+11.7%)
$79.07M(+18.7%)
Mar 2002
-
$17.96M(-17.4%)
$66.60M(+25.0%)
Dec 2001
$53.27M(+43.0%)
$21.74M(+12.6%)
$53.27M(+35.0%)
Sep 2001
-
$19.30M(+154.3%)
$39.47M(+2.7%)
Jun 2001
-
$7.59M(+63.9%)
$38.44M(+1.6%)
Mar 2001
-
$4.63M(-41.6%)
$37.83M(+1.6%)
Dec 2000
$37.26M(+9.8%)
$7.94M(-56.6%)
$37.26M(-4.0%)
Sep 2000
-
$18.28M(+161.7%)
$38.82M(+24.5%)
Jun 2000
-
$6.99M(+72.3%)
$31.18M(-0.7%)
Mar 2000
-
$4.05M(-57.3%)
$31.40M(-7.4%)
Dec 1999
$33.92M(-13.4%)
$9.50M(-10.7%)
$33.92M(+17.9%)
Sep 1999
-
$10.64M(+47.6%)
$28.77M(-26.2%)
Jun 1999
-
$7.21M(+9.6%)
$39.01M(+0.4%)
Mar 1999
-
$6.58M(+51.1%)
$38.85M(-0.8%)
Dec 1998
$39.17M(+20.6%)
$4.35M(-79.2%)
$39.17M(-11.8%)
Sep 1998
-
$20.88M(+196.2%)
$44.42M(+22.9%)
Jun 1998
-
$7.05M(+2.2%)
$36.14M(+3.6%)
Mar 1998
-
$6.89M(-28.2%)
$34.90M(+7.0%)
Dec 1997
$32.47M(+43.9%)
$9.60M(-23.8%)
$32.60M(+10.5%)
Sep 1997
-
$12.60M(+117.2%)
$29.50M(+34.1%)
Jun 1997
-
$5.80M(+26.1%)
$22.00M(+5.3%)
Mar 1997
-
$4.60M(-29.2%)
$20.90M(-7.9%)
Dec 1996
$22.57M(+74.1%)
$6.50M(+27.5%)
$22.70M(+15.8%)
Sep 1996
-
$5.10M(+8.5%)
$19.60M(+7.7%)
Jun 1996
-
$4.70M(-26.6%)
$18.20M(+8.3%)
Mar 1996
-
$6.40M(+88.2%)
$16.80M(+29.2%)
Dec 1995
$12.97M(+28.5%)
$3.40M(-8.1%)
$13.00M(+71.1%)
Sep 1995
-
$3.70M(+12.1%)
$7.60M(+7.0%)
Jun 1995
-
$3.30M(+26.9%)
$7.10M(+2.9%)
Mar 1995
-
$2.60M(-230.0%)
$6.90M(0.0%)
Dec 1994
$10.09M(-5.3%)
-$2.00M(-162.5%)
$6.90M(-41.5%)
Sep 1994
-
$3.20M(+3.2%)
$11.80M(-0.8%)
Jun 1994
-
$3.10M(+19.2%)
$11.90M(-0.8%)
Mar 1994
-
$2.60M(-10.3%)
$12.00M(-0.8%)
Dec 1993
$10.65M(+22.1%)
$2.90M(-12.1%)
$12.10M(+23.5%)
Sep 1993
-
$3.30M(+3.1%)
$9.80M(0.0%)
Jun 1993
-
$3.20M(+18.5%)
$9.80M(+10.1%)
Mar 1993
-
$2.70M(+350.0%)
$8.90M(+2.3%)
Dec 1992
$8.73M(+39.4%)
$600.00K(-81.8%)
$8.70M(-2.2%)
Sep 1992
-
$3.30M(+43.5%)
$8.90M(+17.1%)
Jun 1992
-
$2.30M(-8.0%)
$7.60M(+11.8%)
Mar 1992
-
$2.50M(+212.5%)
$6.80M(+17.2%)
Dec 1991
$6.26M(+213.1%)
$800.00K(-60.0%)
$5.80M(+5.5%)
Sep 1991
-
$2.00M(+33.3%)
$5.50M(+37.5%)
Jun 1991
-
$1.50M(0.0%)
$4.00M(+33.3%)
Mar 1991
-
$1.50M(+200.0%)
$3.00M(+50.0%)
Dec 1990
$2.00M
$500.00K(0.0%)
$2.00M(+33.3%)
Sep 1990
-
$500.00K(0.0%)
$1.50M(+50.0%)
Jun 1990
-
$500.00K(0.0%)
$1.00M(+100.0%)
Mar 1990
-
$500.00K
$500.00K

FAQ

  • What is Ionis Pharmaceuticals, Inc. annual revenue?
  • What is the all time high annual revenue for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. annual revenue year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. quarterly revenue?
  • What is the all time high quarterly revenue for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. quarterly revenue year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. TTM revenue?
  • What is the all time high TTM revenue for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. TTM revenue year-on-year change?

What is Ionis Pharmaceuticals, Inc. annual revenue?

The current annual revenue of IONS is $705.14M

What is the all time high annual revenue for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high annual revenue is $1.12B

What is Ionis Pharmaceuticals, Inc. annual revenue year-on-year change?

Over the past year, IONS annual revenue has changed by -$82.51M (-10.48%)

What is Ionis Pharmaceuticals, Inc. quarterly revenue?

The current quarterly revenue of IONS is $452.05M

What is the all time high quarterly revenue for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high quarterly revenue is $493.68M

What is Ionis Pharmaceuticals, Inc. quarterly revenue year-on-year change?

Over the past year, IONS quarterly revenue has changed by +$226.80M (+100.69%)

What is Ionis Pharmaceuticals, Inc. TTM revenue?

The current TTM revenue of IONS is $944.48M

What is the all time high TTM revenue for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high TTM revenue is $1.12B

What is Ionis Pharmaceuticals, Inc. TTM revenue year-on-year change?

Over the past year, IONS TTM revenue has changed by +$130.52M (+16.04%)
On this page